Your browser is no longer supported. Please, upgrade your browser.
Settings
RATE Bankrate, Inc. daily Stock Chart
RATE [NYSE]
Bankrate, Inc.
Index- P/E- EPS (ttm)-0.25 Insider Own3.60% Shs Outstand89.38M Perf Week-0.36%
Market Cap1.24B Forward P/E16.89 EPS next Y0.82 Insider Trans-2.14% Shs Float47.74M Perf Month0.00%
Income-22.00M PEG- EPS next Q0.22 Inst Own48.40% Short Float1.55% Perf Quarter0.36%
Sales477.00M P/S2.60 EPS this Y-321.30% Inst Trans0.54% Short Ratio1.21 Perf Half Y40.40%
Book/sh7.58 P/B1.83 EPS next Y17.07% ROA-2.00% Target Price12.67 Perf Year79.35%
Cash/sh2.11 P/C6.59 EPS next 5Y10.00% ROE-3.20% 52W Range7.10 - 14.25 Perf YTD25.79%
Dividend- P/FCF16.70 EPS past 5Y-21.80% ROI-1.50% 52W High-2.46% Beta1.65
Dividend %- Quick Ratio2.40 Sales past 5Y0.50% Gross Margin46.60% 52W Low95.77% ATR0.05
Employees600 Current Ratio2.40 Sales Q/Q17.90% Oper. Margin-0.10% RSI (14)45.92 Volatility0.36% 0.36%
OptionableYes Debt/Eq0.44 EPS Q/Q44.10% Profit Margin-4.60% Rel Volume0.21 Prev Close13.90
ShortableYes LT Debt/Eq0.44 EarningsNov 02 AMC Payout- Avg Volume611.37K Price13.90
Recom3.00 SMA20-0.25% SMA500.02% SMA20016.36% Volume128,472 Change0.00%
Jul-05-17Downgrade Needham Buy → Hold
Jul-03-17Downgrade Sidoti Buy → Neutral
Feb-08-17Initiated Oppenheimer Outperform $14
Aug-11-16Initiated Loop Capital Hold $9
Jun-02-16Initiated Compass Point Neutral $9
Feb-26-16Upgrade Goldman Sell → Neutral
Feb-25-16Downgrade Topeka Capital Markets Buy → Hold $19 → $9
Feb-25-16Downgrade RBC Capital Mkts Outperform → Sector Perform $16 → $9
Feb-08-16Initiated Sidoti Buy
Nov-23-15Reiterated Needham Buy $14 → $20
Nov-18-15Initiated Topeka Capital Markets Buy $19
Nov-09-15Upgrade BofA/Merrill Neutral → Buy
Aug-05-15Reiterated RBC Capital Mkts Outperform $18 → $15
Jun-22-15Resumed Needham Buy $14
Jun-18-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral $18 → $12
Sep-16-14Downgrade Topeka Capital Markets Hold → Sell
Jun-05-14Upgrade RBC Capital Mkts Sector Perform → Outperform $21
Feb-14-14Reiterated Canaccord Genuity Hold $17 → $20
Oct-31-13Downgrade Stifel Buy → Hold
Sep-30-13Reiterated Stifel Buy $20 → $23
Oct-17-17 08:03AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Oct-16-17 09:43AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Oct-11-17 08:02AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Oct-09-17 08:04AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Oct-06-17 08:04AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Sep-28-17 07:45AM  Bankrate: Mortgage Rates Show Little Change PR Newswire
Sep-27-17 08:35AM  Americans Fear D.C. Politics More than North Korea PR Newswire
Sep-26-17 10:32AM  Red Ventures, LLC -- Moody's assigns first-time B2 CFR to Red Ventures, rates new first-lien credit facilities B1; outlook stable Moody's
Sep-21-17 07:45AM  Bankrate: Mortgage Rates Move Back Above 4 Percent PR Newswire
Sep-19-17 08:55PM  Bankrate, Inc. Value Analysis (NYSE:RATE) : September 20, 2017 Capital Cube
Sep-18-17 09:00AM  Nearly Half of Americans Plan to Make a Substantial Purchase This Year PR Newswire
08:16AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : September 18, 2017 Capital Cube
Sep-14-17 04:25PM  Red Ventures' proposed $1.4B merger with Bankrate moving forward American City Business Journals
07:45AM  Bankrate: Mortgage Rates Rebound Slightly PR Newswire
Sep-13-17 04:05PM  Bankrate Stockholders Approve Merger With Red Ventures PR Newswire
02:39PM  Vanguard: QT Will Be Tricky and Lead to Pause in Fed Rate Hikes Barrons.com
Sep-12-17 08:03AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Sep-07-17 07:45AM  Bankrate: Mortgage Rates Dip for 3rd Consecutive Week PR Newswire
Sep-06-17 07:57AM  As Mortgage Rates Fall, Refinancing Activity Jumps Barrons.com
Sep-05-17 08:02AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Aug-31-17 07:30AM  Bankrate: Mortgage Rates Set 2017 Low PR Newswire
Aug-30-17 08:45AM  Millions Have Already Booked Holiday Travel PR Newswire
Aug-24-17 07:45AM  Bankrate: Mortgage rates tie lowest level of 2017 PR Newswire
Aug-23-17 04:48PM  ETFs with exposure to Bankrate, Inc. : August 23, 2017 Capital Cube
Aug-22-17 04:35PM  Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Bankrate, Inc. ACCESSWIRE
08:01AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Aug-17-17 07:45AM  Bankrate: Mortgage Rates Remain in Holding Pattern PR Newswire
Aug-16-17 09:25AM  AccessOne needs space for growth in new Kingsley Park building under construction in Fort Mill American City Business Journals
Aug-15-17 08:55AM  Percentage of Working Americans Saving More for Retirement Highest in Six Years PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Aug-11-17 08:02AM  See what the IHS Markit Score report has to say about Bankrate Inc. Markit
Aug-10-17 12:49PM  Bankrate, Inc. :RATE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017 Capital Cube
Aug-09-17 07:45AM  Bankrate: Mortgage Rates Mostly Steady Amid Summer Doldrums PR Newswire
Aug-07-17 11:54PM  Bankrate Inc. reports 2Q loss Associated Press
04:01PM  Bankrate Reports Second Quarter 2017 Financial Results PR Newswire
Aug-03-17 11:49AM  The Law Offices of Vincent Wong Reminds Investors of an Investigation of Bankrate, Inc. in Connection with the Sale of the Company to Red Ventures Holdco, LP Business Wire
07:45AM  Bankrate: Mortgage Rates Fall for 4th Week in a Row PR Newswire
Jul-27-17 07:50PM  Bankrate, Inc. To Report Second Quarter 2017 Earnings On August 7, 2017 PR Newswire
07:30AM  Bankrate: Mortgage Rates Inch Lower as Fed Holds Rates Steady PR Newswire
Jul-20-17 08:55AM  Millennial Spending Habits Differ From Older Generations PR Newswire
07:45AM  Bankrate: Mortgage Rates Retreat for Second Week in a Row PR Newswire
Jul-19-17 04:59PM  The Law Offices of Vincent Wong Notifies Investors of an Investigation of Bankrate, Inc. in Connection with the Sale of the Company to Red Ventures Holdco, LP Business Wire
02:40PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) Accesswire
08:45AM  Real Estate is Americans' Favorite Long-Term Investment PR Newswire
Jul-17-17 02:16PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Bankrate, Inc. to Red Ventures Holdco, LP is Fair to Shareholders RATE Business Wire
Jul-13-17 12:59PM  SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Bankrate, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
Jul-12-17 03:57PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Bankrate, Inc. - RATE PR Newswire
12:58PM  BANKRATE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
10:51AM  Over 44 Million Americans Have a Side Hustle PR Newswire
Jul-11-17 06:06PM  WEISSLAW LLP: Bankrate, Inc. Acquisition May Not Be in the Best Interests of RATE Shareholders PR Newswire
04:09PM  BANKRATE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bankrate, Inc. PR Newswire
09:49AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Bankrate, Inc. to Red Ventures Holdco, LP is Fair to Shareholders Business Wire
07:55AM  Rowley Law PLLC Is Investigating Bankrate, Inc. and Its Board of Directors For Potential Breaches Of Fiduciary Duty PR Newswire
Jul-10-17 07:44PM  Harwood Feffer LLP Announces Investigation of Bankrate, Inc. PR Newswire
Jul-07-17 06:05PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Bankrate, Inc. - RATE Accesswire
Jul-06-17 08:00AM  Bankrate: Mortgage Rates Continue to Rise PR Newswire
Jul-05-17 11:38AM  BANKRATE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Red Ventures May be Unfair to Shareholders Business Wire
11:03AM  Bankrate, Inc. -- Moody's says Bankrate's B1 CFR and stable outlook are not immediately impacted by announcement of pending sale to Red Ventures Moody's
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) Accesswire
09:49AM  Company News for July 05, 2017 Zacks
08:45AM  New Cars Unaffordable for Most Americans PR Newswire
08:43AM  CreditCards.com owner Bankrate agrees to $1.4 billion buyout American City Business Journals
08:15AM  Bankrate (RATE) Catches Eye: Stock Jumps 8.6% in Session Zacks
08:15AM  Corporate News Blog - Bankrate to be Acquired by Red Ventures; Set to Generate Greater Scale for Both Businesses Accesswire
Jul-04-17 02:38PM  Bankrate stock pops on $1.4 billion Red Ventures deal American City Business Journals
Jul-03-17 03:43PM  Fiat Chrysler and Bankrate jump while Adobe, Newmont fall Associated Press +8.56%
02:18PM  [$$] Bankrate website to be bought by Red Ventures for $1.24bn Financial Times
01:43PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) PR Newswire
01:39PM  Why Bankrate Stock Surged 10% Today Motley Fool
01:23PM  [$$] PE-Backed Red Ventures to Acquire Personal Finance Website Bankrate The Wall Street Journal
01:23PM  Why Bankrate, Diamond Offshore Drilling, and Teekay Jumped Today Motley Fool
01:02PM  Bankrate Accepts $1.4 Billion Buyout Offer From Red Ventures Investor's Business Daily
12:46PM  [$$] Bankrate to be Acquired by Marketing Firm Red Ventures The Wall Street Journal
11:35AM  Story Stocks from Briefing.com Briefing.com
10:56AM  Red Ventures buys Bankrate Reuters Videos
10:32AM  Merger Monday: 9 M&A Firecrackers Ahead Of Market Holiday Benzinga
08:32AM  BANKRATE (RATE) ALERT: J&W Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Bankrate, Inc.; Are Shareholders Getting a Fair Price? PR Newswire
08:10AM  Bankrate Acquired by Red Ventures in $1.4 Billion Deal 24/7 Wall St.
08:08AM  Early movers: TSLA, GSK, LVS, WYNN, CAT, GS, BMY & more CNBC
08:01AM  Red Ventures to acquire Bankrate in all-cash deal with an enterprise value of $1.4 billion MarketWatch
07:17AM  Red Ventures to acquire Bankrate for $1.24 bln Reuters
07:13AM  Bankrate to be acquired by Red Ventures for about $1.4 billion in cash CNBC
07:01AM  Bankrate to Be Acquired by Red Ventures for $14.00 per Share PR Newswire
Jun-30-17 11:29AM  Bankrate's Charts Are Shaping Up Nicely TheStreet.com
Jun-29-17 09:46AM  Bankrate: Mortgage Rates Inch Higher PR Newswire
Jun-27-17 09:00AM  Nearly 1 in 4 Has No Emergency Savings PR Newswire
Jun-26-17 08:45AM  Millennials Struggle with Financial Vices PR Newswire
Jun-22-17 04:14PM  Stocks Close Mixed As Health Care Leads; 2 Medicals Hit Buy Points Investor's Business Daily
07:35AM  Bankrate: Mortgage Rates Nudge Higher, But Remain Near 7-Month Lows PR Newswire
Jun-15-17 07:45AM  Bankrate: Mortgage Rates Hovering at 7-Month Lows PR Newswire
Jun-14-17 08:42AM  3 Stocks With LendingTree-Like Return Potential Motley Fool
Jun-08-17 07:45AM  Bankrate: Mortgage Rates Hit 7-Month Low PR Newswire
Jun-07-17 08:45AM  1-in-4 American Families Have Not Sought Medical Attention Due to Cost PR Newswire
Jun-02-17 02:26PM  ETFs with exposure to Bankrate, Inc. : June 2, 2017 Capital Cube
Jun-01-17 07:30AM  Bankrate: Mortgage Rates At Lowest Since Mid-November PR Newswire
May-25-17 08:45AM  Houston is the Best City to Start a Career PR Newswire
07:30AM  Bankrate: Mortgage Rates Hit Six-Month Low PR Newswire
May-23-17 08:45AM  73% Have Financial Regrets PR Newswire
May-17-17 08:45AM  Millennials Think Parents Should Stop Helping with Bills at Earlier Ages PR Newswire -5.99%
May-15-17 04:26PM  ETFs with exposure to Bankrate, Inc. : May 15, 2017 Capital Cube
Bankrate, Inc. operates as a publisher, aggregator, and distributor of personal finance content on the Internet. It provides personal finance editorial content across various categories, including credit cards, mortgages, deposits, senior care, and others. The company's flagship Websites CreditCards.com, Bankrate.com, and Caring.com are content destinations and connect its audience with financial service and senior care providers, and contextually relevant advertisers. Its Credit Cards segment offers information and comparison capabilities of consumer and business credit and prepaid cards; and host news and advice on personal finance, credit card, and bank policies, as well as tools and calculators to estimate credit scores and card benefits. The company's Banking segment offers information on rates for various types of mortgages, home lending, and refinancing; and rate information and original editorial content on various deposit products, such as money markets, savings, and certificates of deposit, as well as retirement, taxes, and debt management. This segment also provides original articles on topics related to the housing market and loan refinancing; online analytic tools to calculate investment values; and content on topics, such as retirement 401(k) accounts, social security, tax deductions and exemptions, auto loans, debt consolidation, and credit risk. Its Senior Care segment provides visitors with information on senior care services and support; original articles, helpful tools, and an online senior living community directory, as well as offers a local directory covering a range of other senior caregiving services. Bankrate, Inc. also develops and provides content, tools, Web services, and co-branded Websites to approximately 100 online partners, including personal finance sites. The company was formerly known as ilife.com Inc. and changed its name to Bankrate, Inc. in 2000. Bankrate, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Speltz Christopher JCEO, Credit CardsJun 27Sale12.957339,492279,000Jun 29 04:30 PM
Barnhart StevenSVP, Chief Financial OfficerJun 22Sale12.009,712116,544295,222Jun 23 04:30 PM
Speltz Christopher JCEO, Credit CardsJun 22Sale11.9512,300146,985279,733Jun 23 04:30 PM
Kim Kenneth ScottCEO, Bankrate.comJun 01Sale10.4528,086293,583179,554Jun 05 05:30 PM
Speltz Christopher JCEO, Credit CardsMay 05Sale11.952002,390292,033May 09 05:00 PM
Speltz Christopher JCEO, Credit CardsApr 27Sale10.9512,500136,875292,233Apr 28 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerApr 25Sale10.256,40265,621304,934Apr 25 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerApr 24Sale10.253003,075311,336Apr 25 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerMar 14Sale10.036,70267,238222,703Mar 14 05:53 PM
Barnhart StevenSVP, Chief Financial OfficerMar 13Sale10.255,44055,778229,405Mar 14 05:53 PM
Gilmartin JamesSVP, General CounselMar 13Sale10.355,00051,75087,170Mar 14 05:50 PM
PMC PharMerica Corporation daily Stock Chart
PMC [NYSE]
PharMerica Corporation
Index- P/E39.39 EPS (ttm)0.74 Insider Own1.00% Shs Outstand31.07M Perf Week0.00%
Market Cap905.69M Forward P/E13.30 EPS next Y2.19 Insider Trans0.00% Shs Float29.56M Perf Month0.52%
Income23.20M PEG4.05 EPS next Q0.50 Inst Own94.50% Short Float1.31% Perf Quarter12.77%
Sales2.21B P/S0.41 EPS this Y-39.20% Inst Trans-0.26% Short Ratio0.78 Perf Half Y24.04%
Book/sh17.71 P/B1.65 EPS next Y13.11% ROA1.90% Target Price29.56 Perf Year5.08%
Cash/sh0.43 P/C67.09 EPS next 5Y9.72% ROE4.20% 52W Range19.20 - 29.50 Perf YTD15.90%
Dividend- P/FCF13.42 EPS past 5Y-2.70% ROI3.10% 52W High-1.19% Beta0.82
Dividend %- Quick Ratio1.80 Sales past 5Y0.10% Gross Margin15.40% 52W Low51.82% ATR0.09
Employees5700 Current Ratio2.60 Sales Q/Q13.90% Oper. Margin2.00% RSI (14)49.73 Volatility0.22% 0.34%
OptionableYes Debt/Eq0.78 EPS Q/Q84.10% Profit Margin1.10% Rel Volume0.16 Prev Close29.20
ShortableYes LT Debt/Eq0.75 EarningsNov 08 BMO Payout0.00% Avg Volume497.32K Price29.15
Recom3.30 SMA20-0.13% SMA500.12% SMA20012.25% Volume77,634 Change-0.17%
Aug-04-17Downgrade Credit Suisse Outperform → Neutral
Jun-07-16Resumed BofA/Merrill Buy
May-10-16Reiterated Barrington Research Outperform $30 → $34
Mar-16-16Initiated Credit Suisse Outperform
Mar-14-16Downgrade UBS Buy → Neutral $40 → $22
Feb-29-16Reiterated Barrington Research Outperform $39 → $30
Feb-29-16Reiterated Barclays Underweight $27 → $22
Aug-10-15Upgrade UBS Neutral → Buy $31 → $40
Aug-10-15Reiterated Barrington Research Outperform $33 → $38
Jan-13-14Reiterated Barclays Underweight $16 → $20
Jan-08-14Reiterated Barclays Underweight $14 → $16
Feb-11-13Downgrade RBC Capital Mkts Outperform → Sector Perform
Apr-25-12Reiterated UBS Neutral $15 → $13
Oct-03-11Reiterated UBS Neutral $13 → $15
Apr-28-11Downgrade Stifel Nicolaus Buy → Hold
Jan-19-11Reiterated Oppenheimer Perform $12 → $14
Nov-08-10Reiterated Oppenheimer Perform $10 → $12
Sep-21-10Reiterated UBS Neutral $13 → $10.50
Aug-18-10Downgrade Barclays Capital Overweight → Equal Weight $19 → $10
Aug-09-10Downgrade RBC Capital Mkts Outperform → Sector Perform $19 → $10
Oct-16-17 04:15PM  Onco360 Selected for VERZENIO® Limited Distribution Pharmacy Network Business Wire
Oct-06-17 03:50PM  PharMerica details millions in golden parachute money for executives American City Business Journals
Oct-03-17 05:00PM  Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica Corporation PR Newswire
Sep-29-17 08:58AM  PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-12-17 01:40PM  PharMerica Corporation -- Moody's assigns B2 CFR to PharMerica Corporation; outlook stable Moody's
Sep-10-17 08:31AM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PharMerica Corporation -- PMC PR Newswire
Sep-04-17 02:13PM  Private Briefing: KKR's Healthcare Deal Spree TheStreet.com
Aug-11-17 05:16AM  Envision Healthcare Hurt by High Debt, Increasing Expenses Zacks
Aug-04-17 07:10AM  Featured Company News - Global Investment Firm KKR and Walgreens Boots Alliance Acquire Institutional Pharmacy Services Company PharMerica ACCESSWIRE
Aug-03-17 05:35PM  PharMerica Corp.: Strong price momentum but will it sustain? Capital Cube
05:30PM  Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of PharMerica Corporation (PMC) on Behalf of Stockholders and Encourages Investors to Contact the Firm Business Wire
04:25PM  PHARMERICA CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
04:15PM  PHARMERICA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PharMerica Corporation PR Newswire
12:06PM  PHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by KKR & Co. L.P. Unit May be Unfair to Shareholders Business Wire
09:47AM  Healthcare Q2 Earnings to Watch Out on Aug 4: WCG & PMC Zacks
08:25AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 3, 2017 Capital Cube
Aug-02-17 10:51PM  PharMerica meets 2Q profit forecasts Associated Press +15.57%
05:30PM  Rowley Law PLLC is Investigating PharMerica Corporation and its Board of Directors for Potential Breaches of Fiduciary Duty PR Newswire
03:49PM  The Law Offices of Vincent Wong Notifies Investors of an Investigation into Possible Breaches of Fiduciary Duty by the Board of PharMerica Corporation in Connection with the Sale of the Company to KR and Walgreens Boots Alliance, Inc. Business Wire
03:45PM  PharMerica Corporation (PMC) Shares Surge on Walgreens, Going Private InvestorPlace
02:59PM  WeissLaw LLP: PharMerica Corp. Acquisition May Not Be in the Best Interests of PMC Shareholders PR Newswire
12:43PM  Harwood Feffer LLP Announces Investigation of Proposed Sale of PharMerica Corporation PR Newswire
12:21PM  Why PharMerica Stock Is Soaring Today Motley Fool
10:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of PharMerica Corporation to KKR and Walgreens Boots Alliance, Inc. is Fair to Shareholders Business Wire
10:34AM  PharMerica to be acquired for $1.4 billion American City Business Journals
09:59AM  Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues TheStreet.com
09:24AM  Stocks to Watch: Apple, Mondelez, PharMerica, AMC Entertainment, AutoNation The Wall Street Journal
09:02AM  PharMerica (PMC) Alert: J&W Investigates Proposed Sale of PharMerica Corporation; Is $29.25 a Fair Price? PR Newswire
08:16AM  [$$] PharMerica to Be Taken Private by KKR-Backed Company The Wall Street Journal
07:22AM  PharMerica reports in-line earnings, will be acquired and taken private MarketWatch
07:01AM  PharMerica Reports Second Quarter 2017 Results Business Wire
07:00AM  PharMerica Corporation Enters into Definitive Agreement to Be Acquired by KKR for $29.25 per Share in Cash Business Wire
Aug-01-17 07:19PM  PharMerica Corp. Value Analysis (NYSE:PMC) : August 1, 2017 Capital Cube
Jul-27-17 08:30AM  First Choice Appoints New CFO to Help Lead Company Through Next Phase of Strategic Execution GlobeNewswire
Jul-20-17 04:15PM  PharMerica Corporation Announces Second Quarter 2017 Earnings Call and Webcast Business Wire
Jul-19-17 09:04AM  PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : July 19, 2017 Capital Cube
Jun-26-17 04:43PM  ETFs with exposure to PharMerica Corp. : June 26, 2017 Capital Cube
12:09PM  Edited Transcript of PMC earnings conference call or presentation 10-May-17 2:00pm GMT Thomson Reuters StreetEvents
Jun-08-17 01:52PM  ETFs with exposure to PharMerica Corp. : June 8, 2017 Capital Cube
11:02AM  Top Ranked Growth Stocks to Buy for June 8th Zacks
Jun-06-17 09:20AM  PharMerica Corp. :PMC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Capital Cube
May-10-17 01:05PM  PharMerica beats 1Q estimates, reveals acquisition American City Business Journals
08:08AM  PharMerica beats 1Q profit forecasts Associated Press
08:00AM  PharMerica Reports First Quarter 2017 Results Business Wire
May-03-17 08:54AM  Pharmerica reveals how much executives made in 2016 American City Business Journals
Apr-27-17 05:07PM  PharMerica Corp. Value Analysis (NYSE:PMC) : April 27, 2017 Capital Cube
Apr-26-17 08:37AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : April 26, 2017 Capital Cube
Apr-19-17 04:15PM  PharMerica Corporation Announces First Quarter 2017 Earnings Call and Webcast Business Wire
Apr-07-17 04:15PM  PharMerica Announces Date of 2017 Annual Meeting of Shareholders Business Wire
Mar-30-17 04:11PM  PHARMERICA CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statem
Mar-17-17 03:20PM  PharMerica Takes Over CareMed, Expands in Specialty Pharmacy Zacks
Mar-16-17 04:15PM  PharMerica Acquires CareMed Specialty Pharmacy Business Wire
Mar-08-17 09:47AM  PharMerica (PMC): Moving Average Crossover Alert Zacks
Mar-07-17 12:45PM  PharMerica Corp. :PMC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Capital Cube
12:45PM  PharMerica Corp. :PMC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
Mar-02-17 01:04PM  PHARMERICA CORP Financials
Feb-27-17 09:05AM  PHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Feb-24-17 02:45PM  Pharmerica increases goal for merger revenue in Q4 earnings call at bizjournals.com -5.42%
02:45PM  Pharmerica increases goal for merger revenue in Q4 earnings call American City Business Journals
11:21AM  Edited Transcript of PMC earnings conference call or presentation 24-Feb-17 3:00pm GMT Thomson Reuters StreetEvents
10:00AM  PharMerica Corp Earnings Call scheduled for 10:00 am ET today
08:28AM  PharMerica beats 4Q profit forecasts Associated Press
08:00AM  PharMerica Reports Fourth Quarter and Full Year 2016 Results Business Wire
07:07AM  Q4 2016 PharMerica Corp Earnings Release - Before Market Open
Feb-14-17 08:25AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : February 14, 2017 Capital Cube
08:25AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : February 14, 2017
Feb-03-17 04:30PM  PharMerica Corporation Announces Fourth Quarter and Year End 2016 Earnings Call and Webcast Business Wire
Feb-01-17 05:09PM  PHARMERICA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-31-17 09:00AM  PharMerica Appoints Robert E. Dries as Executive Vice President and Chief Financial Officer Business Wire
Jan-24-17 10:36AM  PharMerica Corp. Value Analysis (NYSE:PMC) : January 24, 2017
Jan-23-17 07:36AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : January 23, 2017
Dec-19-16 08:27AM  PharMerica Amends Credit Facility, Ups Borrowing Capacity
Dec-15-16 04:51PM  PHARMERICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S
04:15PM  PharMerica Announces Expansion of Existing Credit Facility, Increasing Borrowing Capacity by $150 Million Business Wire
Dec-09-16 01:53PM  ETFs with exposure to PharMerica Corp. : December 9, 2016
07:22AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : December 9, 2016
Dec-05-16 02:22PM  Should You Avoid PharMerica Corporation (PMC)? at Insider Monkey
Nov-18-16 10:47AM  PharMerica Corp. :PMC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-09-16 11:00AM  Edited Transcript of PMC earnings conference call or presentation 9-Nov-16 3:00pm GMT +11.06%
10:00AM  PharMerica Corp Earnings Call scheduled for 10:00 am ET today
08:09AM  PharMerica misses 3Q profit forecasts
08:03AM  PHARMERICA CORP Files SEC form 10-Q, Quarterly Report
08:01AM  PHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  PharMerica Reports Third Quarter 2016 Results Business Wire
07:07AM  Q3 2016 PharMerica Corp Earnings Release - Before Market Open
Oct-31-16 08:32AM  PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 31, 2016
Oct-14-16 04:30PM  PharMerica Corporation Announces Third Quarter 2016 Earnings Call and Webcast Business Wire
Aug-31-16 08:33AM  5 Health Care Stocks John Paulson Is Betting On in 2016
Aug-30-16 11:20AM  What can Pharmerica do to get buyers to swipe right? at bizjournals.com
Aug-25-16 04:14PM  PharMerica Corp.: Strong price momentum but will it sustain?
08:05AM  PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 25, 2016
Aug-24-16 08:23PM  Why PharMerica Soared 13.4% Today at Motley Fool +13.39%
05:03PM  Report: Louisville's Pharmerica may sell at bizjournals.com
03:50PM  PharMerica (PMC) Stock Soars, Exploring Possible Sale
01:40PM  [$$] PharMerica Exploring Strategic Alternatives, Including Sale at The Wall Street Journal
11:03AM  Specialty pharmacy PharMerica explores possible sale -sources Reuters
Aug-23-16 12:19PM  ETFs with exposure to PharMerica Corp. : August 23, 2016
Aug-12-16 12:15PM  PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 01:03PM  ETFs with exposure to PharMerica Corp. : August 11, 2016
08:46AM  One of Pharmerica's top execs plans to retire at bizjournals.com
PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs; consultant pharmacist services and medical records services; and care management and other related services to patients, oncology practices, and hospitals. It operates 99 institutional, 19 specialty infusion, and 4 specialty oncology pharmacies in 45 states. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care providers. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEISHAR GREGORY SChief Executive OfficerMar 15Option Exercise18.48155,8362,879,849964,810Mar 17 04:30 PM
MEYERS GEOFFREY GDirectorOct 31Option Exercise15.0629,268440,77672,943Nov 03 05:47 PM
DAC Danaos Corporation daily Stock Chart
DAC [NYSE]
Danaos Corporation
Index- P/E- EPS (ttm)-3.79 Insider Own58.70% Shs Outstand102.47M Perf Week3.45%
Market Cap153.71M Forward P/E1.61 EPS next Y0.93 Insider Trans0.00% Shs Float19.58M Perf Month0.00%
Income-416.30M PEG- EPS next Q0.23 Inst Own2.00% Short Float2.33% Perf Quarter-33.33%
Sales447.80M P/S0.34 EPS this Y-412.90% Inst Trans-0.23% Short Ratio4.38 Perf Half Y-11.76%
Book/sh4.50 P/B0.33 EPS next Y4.49% ROA-12.90% Target Price3.00 Perf Year-38.78%
Cash/sh0.62 P/C2.41 EPS next 5Y3.00% ROE-69.90% 52W Range1.25 - 4.40 Perf YTD-43.40%
Dividend- P/FCF0.70 EPS past 5Y26.80% ROI-7.10% 52W High-65.91% Beta1.32
Dividend %- Quick Ratio0.00 Sales past 5Y1.30% Gross Margin72.90% 52W Low20.00% ATR0.11
Employees1196 Current Ratio0.10 Sales Q/Q-16.90% Oper. Margin-57.40% RSI (14)53.56 Volatility7.78% 6.73%
OptionableNo Debt/Eq4.87 EPS Q/Q-54.70% Profit Margin-93.00% Rel Volume1.32 Prev Close1.50
ShortableYes LT Debt/Eq0.00 EarningsOct 30 AMC Payout- Avg Volume104.31K Price1.50
Recom3.00 SMA203.99% SMA501.04% SMA200-18.18% Volume138,029 Change0.00%
Feb-20-15Initiated Global Hunter Securities Neutral
Sep-18-14Resumed Clarkson Capital Hold
Apr-17-13Initiated Global Hunter Securities Neutral
Apr-24-09Downgrade Jefferies & Co Buy → Hold $6 → $5
Mar-13-09Reiterated Jefferies & Co Buy $22 → $6
Nov-04-08Reiterated Jefferies & Co Buy $46 → $22
Jan-29-08Initiated Oppenheimer Outperform $36
Nov-20-07Initiated Lazard Capital Buy $39
Jul-18-07Initiated Credit Suisse Outperform $37
Jan-25-07Reiterated Fortis Bank Buy $23 → $27
Sep-11-17 01:26PM  Danaos Corp. :DAC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 Capital Cube +7.14%
Aug-01-17 07:20AM  Investor Network: Danaos Corporation to Host Earnings Call ACCESSWIRE
Jul-31-17 10:06PM  Danaos posts 2Q profit Associated Press
04:30PM  Danaos Corporation Reports Second Quarter and Half Year Results for the Period Ended June 30, 2017 PR Newswire
Jul-28-17 04:30PM  Danaos Corporation Announces Date for the Release of Second Quarter 2017 Results, Conference Call and Webcast PR Newswire
Jul-13-17 11:46AM  Top Ranked Value Stocks to Buy for July 13th Zacks +18.92%
Jul-12-17 09:45AM  New Strong Buy Stocks for July 12th Zacks +17.46%
Jun-30-17 06:07AM  Will Danaos (DAC) Continue to Surge Higher? Zacks
Jun-28-17 10:44AM  Top Ranked Value Stocks to Buy for June 28th Zacks
08:15AM  Earnings Review and Free Research Report: Dynagas Reports Better Than Expected Earnings Accesswire
Jun-26-17 02:59PM  Danaos Corp. :DAC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 26, 2017 Capital Cube +6.06%
Jun-22-17 10:00AM  Top Ranked Value Stocks to Buy for June 22nd Zacks
May-30-17 04:38PM  Danaos posts 1Q profit Associated Press +8.00%
04:30PM  Danaos Corporation Reports First Quarter Results for the Period Ended March 31, 2017 PR Newswire
May-24-17 04:30PM  Danaos Corporation Announces Date for the Release of First Quarter 2017 Results, Conference Call and Webcast PR Newswire +8.00%
Mar-17-17 08:20AM  Danaos (DAC) Shows Strength: Stock Moves 15.2% Higher Zacks +5.26%
Mar-16-17 08:23AM  Danaos Corp. :DAC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Capital Cube +15.15%
08:23AM  Danaos Corp. :DAC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
Mar-15-17 01:01PM  Danaos Corp. :DAC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-10-17 01:04PM  DANAOS CORP Financials -5.26%
Mar-06-17 04:58PM  Danaos Corporation Announces Availability of its Annual Report on Form 20-F for the Year Ended December 31, 2016 PR Newswire
Feb-21-17 06:04PM  Danaos reports 4Q loss Associated Press
04:30PM  Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2016 PR Newswire
07:07AM  Q4 2016 Danaos Corp Earnings Release - After Market Close
Feb-15-17 04:30PM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2016 Results, Conference Call and Webcast PR Newswire
Dec-22-16 11:07AM  What Makes Danaos (DAC) a Strong Sell? Zacks
Dec-16-16 11:30AM  DryShips Shares Float Higher Again With New Loan TheStreet.com
11:30AM  DryShips Shares Float Higher Again With New Loan
Dec-15-16 04:40PM  Danaos reports 3Q loss +5.17%
04:30PM  Danaos Corporation Reports Third Quarter and Nine Months Results for the Period Ended September 30, 2016 PR Newswire
07:07AM  Q3 2016 Danaos Corp Earnings Release - After Market Close
Dec-13-16 04:48PM  Danaos Corporation Announces Date for the Release of Third Quarter 2016 Results, Conference Call and Webcast PR Newswire
Nov-21-16 08:26AM  Shipping Stocks' Q3 Earnings Round the Corner: GOGL, DAC
Nov-16-16 06:08PM  Why Fossil Group, Advanced Micro Devices, and Danaos Jumped Today at Motley Fool +8.96%
03:24PM  Danaos Corp.: Price momentum supported by strong fundamentals
07:39AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : DAC-US : November 16, 2016
Nov-15-16 04:02PM  Why Shipping Stocks Skyrocketed Higher Today at Motley Fool +42.55%
Nov-08-16 09:39AM  Best of the Worst: Can We Find a Container Shipping Company to Invest In? at Motley Fool -8.00%
Nov-07-16 07:27AM  Transport Stock Earnings to Watch on Nov 8 - EXPD, TGH, DAC
Oct-10-16 09:00AM  Capital Link's 6th Annual Operational Excellence & Maritime CSR Forum Wednesday, November 2, 2016 in London, UK Marketwired
Sep-09-16 04:26PM  Danaos Corp.: Price momentum supported by strong fundamentals
Sep-01-16 08:00AM  Danaos Corporation Receives Notice that Counterparty has Entered into Court Receivership PR Newswire -11.46%
Aug-30-16 01:45PM  Will Seaspan Corporation Raise Its Dividend in 2017? at Motley Fool
Aug-18-16 08:09AM  Danaos Corp. breached its 50 day moving average in a Bearish Manner : DAC-US : August 18, 2016
Aug-15-16 04:15PM  3 Things Seaspan Corporation's CEO Wants You to Know at Motley Fool
Aug-11-16 05:24AM  Navigator Holdings (NVGS) in Focus: Stock Up 7% in Session
Aug-10-16 01:11PM  Danaos Corp. :DAC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
08:34AM  Should You Get Rid of Kirby (KEX) Now?
Aug-03-16 09:30AM  Zacks.com featured highlights: Danaos, Telecom Italia, Fibria Celulose, Goodyear Tire & Rubber and Zafgen
08:25AM  Ardmore Shipping (ASC) in Focus: Stock Moves 9.4% Higher
Aug-01-16 05:06PM  Danaos posts 2Q profit
04:30PM  Danaos Corporation Reports Second Quarter and Half Year Results for the Period Ended June 30, 2016 PR Newswire
07:07AM  Q2 2016 Danaos Corp Earnings Release - After Market Close
Jul-29-16 08:39AM  Transport Stocks' Q2 Earnings on Aug 1: DAC, RAIL & Others
Jul-25-16 08:51AM  What Makes Navigator Holdings (NVGS) a Strong Sell?
Jul-21-16 04:30PM  Danaos Corporation Announces Date for the Release of Second Quarter 2016 Results, Conference Call and Webcast Marketwired
Jul-20-16 08:05AM  Star Bulk Carriers (SBLK) in Focus: Stock Up 5.3% in Session +5.57%
Jul-19-16 09:30AM  Zacks.com featured highlights: Stamps.com, ReneSola and Danaos
08:30AM  Capital Product (CPLP) Soars: Stock Adds 7.6% in Session
Jul-18-16 03:39PM  Danaos Corp. Value Analysis (NYSE:DAC) : July 18, 2016 +7.43%
Jul-12-16 06:53AM  Can the Rally in Danaos (DAC) Shares Continue?
Jul-11-16 08:54AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : DAC-US : July 11, 2016 +5.94%
Jul-08-16 08:35AM  Aegean Marine Petroleum (ANW) in Focus: Stock Jumps 5.6% +23.17%
08:05AM  3 Reasons Why Danaos Corporation (DAC) is a Great Value Stock
Jul-07-16 08:58AM  Why Scorpio Tankers (STNG) Could Be Positioned for a Slump +11.19%
08:25AM  Danaos (DAC) Shows Strength: Stock Adds 8.5% in Session
Jun-21-16 10:29AM  Maersk battles to stay on top as container shipping downturn deepens
Jun-17-16 03:15PM  Seaspan Corporation Refuses to Throw a Lifeline to a Sinking Customer at Motley Fool
May-31-16 10:05AM  Has Seaspan Corporation Done Enough to Shore Up Its Finances? at Motley Fool
May-23-16 04:14PM  Danaos Corp.: Price momentum supported by strong fundamentals -5.48%
May-10-16 09:05AM  Industry Leaders at Capital Link's Analyst & Investor Day on June 6, 2016 at Athens, Greece Marketwired
May-06-16 11:29AM  Danaos Corp. :DAC-US: Earnings Analysis: Q1, 2016 By the Numbers -12.95%
May-04-16 06:42PM  Danaos posts 1Q profit +6.10%
04:30PM  Danaos Corporation Reports First Quarter Results for the Period Ended March 31, 2016 Marketwired
07:07AM  Q1 2016 Danaos Corp Earnings Release - After Market Close
Apr-21-16 04:39PM  Danaos Corporation Announces Date for the Release of First Quarter 2016 Results, Conference Call and Webcast Marketwired
Mar-29-16 04:14PM  Greek Billionaire George Economou Buys More Shares of Danaos Corp (DAC) at Insider Monkey
Mar-18-16 08:30AM  Danaos Corporation Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2015 Marketwired
Feb-18-16 10:28AM  Danaos Corp. Earnings Analysis: 2015 By the Numbers
Feb-16-16 05:23PM  Danaos beats 4Q profit forecasts
04:46PM  Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2015 Marketwired
07:07AM  Q4 2015 Danaos Corp Earnings Release - After Market Close
Feb-10-16 09:30AM  New Strong Buy Stocks for February 10th
Feb-02-16 05:24PM  Danaos Corp. Value Analysis (NYSE:DAC) : February 2, 2016
08:05AM  Navigator Holdings (NVGS) in Focus: Stock Rises 6.5%
08:02AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : February 2, 2016
Feb-01-16 09:10AM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2015 Results, Conference Call and Webcast at noodls
09:00AM  Danaos Corporation Announces Date for the Release of Fourth Quarter 2015 Results, Conference Call and Webcast Marketwired
Jan-22-16 08:30AM  KNOT Offshore Partners (KNOP) Jumps: Stock Rises 6.7%
Jan-21-16 08:40AM  Capital Product Partners (CPLP) Jumps: Stock Rises 5.6%
Jan-15-16 02:43PM  Edited Transcript of DAC earnings conference call or presentation 4-Nov-15 2:00pm GMT -5.49%
Jan-13-16 09:30AM  The Zacks Analyst Blog Highlights: Aegean Marine Petroleum Network, Danaos, Tsakos Energy Navigation, Horizon Pharma and ICON Public Limited
Jan-12-16 02:18PM  5 Smart PIIGS Stocks to Buy Now
Jan-01-16 08:01AM  Danaos Corp. breached its 50 day moving average in a Bullish Manner : January 1, 2016
Dec-31-15 04:13PM  Danaos Corp.: Strong price momentum but will it sustain? +8.12%
08:25AM  Danaos Corporation (DAC) Looks Good: Stock Adds 14.9%
Dec-30-15 08:30AM  Diana Containerships (DCIX) Looks Good: Stock Up 5.3% +14.94%
Dec-18-15 09:48AM  Danaos Corp. Earnings Analysis: Q3, 2015 By the Numbers
08:30AM  Teekay Corporation (TK) in Focus: Stock Plunges 58.4%
Dec-14-15 08:55AM  Danaos Corp Stock: 3 Reasons Why DAC Is a Top Choice for Value Investors
Danaos Corporation, together with its subsidiaries, owns and operates containerships in Australia, Asia, and Europe. The company offers seaborne transportation services, such as chartering its vessels to liner companies. As of February 28, 2017, it had a fleet of 55 containerships aggregating 329,588 twenty foot equivalent units. The company was formerly known as Danaos Holdings Limited and changed its name to Danaos Corporation in October 2005. Danaos Corporation was founded in 1972 and is based in Piraeus, Greece.
ACOR Acorda Therapeutics, Inc. daily Stock Chart
ACOR [NASD]
Acorda Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.94 Insider Own1.20% Shs Outstand46.02M Perf Week4.64%
Market Cap1.24B Forward P/E38.42 EPS next Y0.70 Insider Trans135.49% Shs Float45.75M Perf Month15.85%
Income-42.90M PEG- EPS next Q0.65 Inst Own- Short Float13.76% Perf Quarter29.43%
Sales535.10M P/S2.33 EPS this Y-401.70% Inst Trans2.31% Short Ratio7.85 Perf Half Y69.59%
Book/sh15.01 P/B1.80 EPS next Y-59.75% ROA-3.20% Target Price22.88 Perf Year34.24%
Cash/sh- P/C- EPS next 5Y29.00% ROE-6.40% 52W Range13.60 - 33.00 Perf YTD43.88%
Dividend- P/FCF55.57 EPS past 5Y-24.60% ROI-3.00% 52W High-18.03% Beta1.67
Dividend %- Quick Ratio2.00 Sales past 5Y12.20% Gross Margin78.80% 52W Low98.90% ATR0.93
Employees597 Current Ratio2.40 Sales Q/Q9.30% Oper. Margin-3.30% RSI (14)65.23 Volatility3.13% 4.18%
OptionableYes Debt/Eq0.00 EPS Q/Q55.80% Profit Margin-8.00% Rel Volume0.82 Prev Close26.65
ShortableYes LT Debt/Eq0.48 EarningsOct 31 BMO Payout- Avg Volume801.66K Price27.05
Recom2.70 SMA208.36% SMA5016.08% SMA20028.18% Volume655,780 Change1.50%
Oct-06-17Resumed Goldman Sell $20
Jul-11-17Initiated Jefferies Hold
Apr-03-17Downgrade JP Morgan Overweight → Neutral
Feb-15-17Upgrade Goldman Sell → Neutral
Nov-30-16Upgrade JP Morgan Neutral → Overweight
Oct-04-16Resumed Leerink Partners Mkt Perform $25
Mar-30-16Initiated Goldman Sell
Sep-01-15Initiated Raymond James Mkt Perform
Jun-09-15Initiated Guggenheim Neutral
Apr-22-15Resumed Piper Jaffray Neutral
Feb-12-15Initiated MLV & Co Buy $58
Oct-30-14Reiterated MKM Partners Neutral $31.50 → $33
Aug-19-14Resumed Stifel Buy $47
May-07-14Reiterated MKM Partners Neutral $33 → $31.50
Apr-17-14Initiated Canaccord Genuity Hold $37
Apr-14-14Upgrade FBR Capital Mkt Perform → Outperform $30 → $47
Nov-01-13Upgrade MKM Partners Sell → Neutral
Nov-01-13Reiterated FBR Capital Outperform $35 → $30
Oct-30-13Initiated FBR Capital Mkt Perform $35
Oct-01-13Reiterated Aegis Capital Buy $43 → $50
Oct-18-17 04:59PM  Pricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
Oct-10-17 07:00AM  Acorda Third Quarter 2017 Update: Webcast/Conference Call Scheduled for October 31, 2017 Business Wire
Oct-09-17 04:39PM  Acorda Therapeutics Inc (ACOR): How Does It Impact Your Portfolio? Simply Wall St.
Oct-04-17 08:05AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
Oct-03-17 08:06AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
03:00AM  Acorda Therapeutics Shows Market Leadership With Jump To 91 RS Rating Investor's Business Daily
Oct-02-17 08:05AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit +9.94%
Sep-26-17 03:00AM  Acorda Therapeutics Getting Closer To Key Technical Measure Investor's Business Daily
Sep-25-17 03:55PM  ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm PR Newswire
Sep-21-17 08:06AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
Sep-18-17 08:06AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
Sep-13-17 07:00AM  Acorda to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-12-17 08:01PM  Should You Buy Acorda Therapeutics Inc (ACOR) Now? Simply Wall St.
08:04AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
Sep-11-17 03:00AM  Acorda Therapeutics Earns RS Rating Upgrade Investor's Business Daily
Sep-08-17 01:22PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Acorda Therapeutics, Inc. Business Wire
Sep-07-17 11:59AM  ETFs with exposure to Acorda Therapeutics, Inc. : September 7, 2017 Capital Cube
03:00AM  Stocks Showing Rising Market Leadership: Acorda Therapeutics Earns 83 RS Rating Investor's Business Daily
Sep-05-17 05:39PM  ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm Business Wire
02:19PM  Acorda Therapeutics, Inc. :ACOR-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
07:40AM  Featured Company News Acorda Therapeutics Adopts Poison Pill ACCESSWIRE
Sep-01-17 10:24PM  Acorda Therapeutics, Inc. Value Analysis (NASDAQ:ACOR) : September 2, 2017 Capital Cube
07:00AM  Acorda Adopts Shareholder Rights Plan Business Wire
Aug-31-17 08:42AM  Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update Zacks +6.39%
Aug-30-17 07:14PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Acorda Therapeutics, Inc. Business Wire
03:55PM  ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm ACCESSWIRE
11:44AM  AstraZeneca and Takeda Ink Deal to Develop Parkinson's Drug Zacks
11:06AM  FDA's Refusal-to-File Letter for Inbrija Pushes Acorda Down Zacks
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics Inc. (ACOR) PR Newswire
09:18AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : August 30, 2017 Capital Cube
08:20AM  Today's Research Reports on Stocks to Watch: ImmunoGen, Inc. and Acorda Therapeutics Inc. ACCESSWIRE
08:19AM  Acorda Therapeutics (ACOR) Alert: Shareholder Rights Law Firm J&W Investigates Acorda Therapeutics, Inc.; Encourages Investors to Contact the Firm PR Newswire
Aug-29-17 06:33PM  Acorda Therapeutics, Inc. Investor Alert: Legal Investigation for Potential Securities Law Violations Business Wire -24.32%
05:07PM  What Happened in the Stock Market Today Motley Fool
04:06PM  Acorda Dives To 10-Week Low After FDA Refuses Parkinson's Drug Investor's Business Daily
03:30PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Acorda Therapeutics, Inc. Business Wire
02:52PM  Acorda stock plummets 26% on surprising, puzzling, disconcerting FDA drug decision MarketWatch
02:18PM  Why Acorda Therapeutics Is Losing One-Quarter of Its Value Today Motley Fool
01:29PM  ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm Business Wire
12:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics Inc. - ACOR PR Newswire
12:34PM  Adamas Pharma stock surges 7% after negative FDA decision for rival Acorda's Parkinson's treatment MarketWatch
11:39AM  INVESTOR ALERT: Investigation of Acorda Therapeutics Announced by Holzer & Holzer Business Wire
10:10AM  Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers TheStreet.com
09:50AM  Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter 24/7 Wall St.
09:31AM  Stocks to Watch: Finish Line, Nike, Best Buy, Hain Celestial, Acorda Therapeutics The Wall Street Journal
07:33AM  UPDATE: Acorda Therapeutics shares crater 26% premarket after FDA rejects application for Parkinson's treatment MarketWatch
07:00AM  Acorda Receives Refusal to File Letter from FDA for INBRIJA (CVT-301, levodopa inhalation powder) New Drug Application Business Wire
Aug-28-17 03:00AM  Acorda Therapeutics Earns Relative Strength Rating Upgrade Investor's Business Daily
Aug-25-17 08:06AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit +9.35%
Aug-14-17 08:05AM  See what the IHS Markit Score report has to say about Acorda Therapeutics Inc. Markit
Aug-11-17 11:56PM  Edited Transcript of ACOR earnings conference call or presentation 27-Jul-17 12:30pm GMT Thomson Reuters StreetEvents
11:47PM  [$$] The Payoff in ADP Barrons.com
Aug-10-17 08:06AM  IHS Markit Score Update: Drop in demand for ETFs holding Acorda Therapeutics Inc is a negative sign for its shares Markit
Aug-07-17 08:24PM  Acorda Stiff-Arms Investor's Demand for Sale TheStreet.com
02:41PM  Activists Gonna Activate: Hedge Funds Send Letters To Acorda, Taubman Centers Boards Benzinga
10:56AM  Scopia Capital Management Takes a Stake in Acorda Therapeutics Barrons.com
08:52AM  Scopia boosts stake in Acorda Therapeutics to become the largest shareholder MarketWatch
08:35AM  Acorda Therapeutics investor calls for company to explore sale Reuters
Jul-28-17 02:33PM  Acorda (ACOR) Q2 Earnings Miss Estimates, Revenues in Line Zacks
08:00AM  Today's Research Reports on Trending Tickers: Astrazeneca PLC and Acorda Therapeutics Inc. ACCESSWIRE
01:24AM  Acorda reports 2Q loss Associated Press
Jul-27-17 06:00AM  Acorda Provides Financial and Pipeline Update for Second Quarter 2017 Business Wire
Jul-13-17 03:22PM  ETFs with exposure to Acorda Therapeutics, Inc. : July 13, 2017 Capital Cube
07:00AM  Acorda Second Quarter 2017 Update Webcast/Conference Call Scheduled for July 27, 2017 Business Wire
Jun-30-17 10:02AM  Acorda Files NDA for Parkinson's Disease Candidate Inbrija Zacks
Jun-29-17 04:01PM  Acorda Submits New Drug Application to U.S. Food and Drug Administration for INBRIJATM (CVT-301, Levodopa Inhalation Powder) Business Wire
Jun-26-17 03:14PM  ETFs with exposure to Acorda Therapeutics, Inc. : June 26, 2017 Capital Cube
Jun-21-17 02:18PM  Biotech Insider Just Loaded Up $234 Million Worth the Stock TheStreet.com
Jun-16-17 09:52AM  Biotech Movers: Adamis Shares Jump After FDA Approves Epinephrine Pre-filled Syringe TheStreet.com
Jun-15-17 12:54PM  ETFs with exposure to Acorda Therapeutics, Inc. : June 15, 2017 Capital Cube
Jun-14-17 09:20AM  Acorda Therapeutics, Inc. :ACOR-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-12-17 02:43PM  Acorda Therapeutics, Inc. Value Analysis (NASDAQ:ACOR) : June 12, 2017 Capital Cube
Jun-09-17 08:36AM  Acorda Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ACOR-US : June 9, 2017 Capital Cube
06:15AM  Zacks Initiates on Pulmatrix (NASDAQ:PULM) Zacks Small Cap Research
Jun-07-17 05:42PM  Acorda Presents Phase III Data on PD Candidate CVT-301 Zacks
08:00AM  Today's Research Reports on Top Tech Stocks: GlycoMimetics and Acorda Therapeutics Accesswire
Jun-06-17 04:31PM  Acorda Therapeutics Inc (ACOR): Key Takeaways from CVT-301 Presentation at MDS SmarterAnalyst
10:04AM  Acorda stock surges 10% on positive late-stage Parkinson's results MarketWatch
09:31AM  Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms TheStreet.com
07:48AM  Early movers: GM, HDS, LE, MIK, GIII, THO, ACOR, RBS, BBRY & more CNBC
06:00AM  Acorda Presenting New Tozadenant Data at 2017 MDS Congress Business Wire
Jun-05-17 04:01PM  CVT-301 Phase 3 Data Showed Significantly Improved Motor Function During OFF Periods in Parkinsons Disease Business Wire
Jun-01-17 08:55AM  Why Is Acorda (ACOR) Down 8.4% Since the Last Earnings Report? Zacks +6.52%
May-31-17 07:00AM  Acorda to Present at the Goldman Sachs Healthcare Conference Business Wire
May-25-17 09:16AM  Biogen's Fampyra Conditional Approval Converted to Standard Zacks
May-18-17 07:00AM  Acorda to Present New INBRIJA (Levodopa Inhalation Powder) Phase 3 Data at Upcoming MDS Congress Business Wire
May-02-17 06:00AM  Acorda to Present at the Deutsche Bank 42nd Annual Healthcare Conference Business Wire
Apr-28-17 09:55PM  Edited Transcript of ACOR earnings conference call or presentation 27-Apr-17 12:30pm GMT Thomson Reuters StreetEvents
10:29AM  Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss Zacks
07:00AM  Acorda Expands Alexa Skill Offering for Parkinsons Awareness Month Business Wire
Apr-27-17 09:38PM  Acorda Shares Fall 5% in an Earnings Miss TheStreet.com -5.76%
05:31PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
05:06PM  Acorda Topples To 11-Year Low On Street-Lagging Q1 Sales, Losses Investor's Business Daily
04:07PM  Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports TheStreet.com
03:11PM  Acorda Topples To 11-Year Low On Street-Lagging Q1 Sales, Losses Investor's Business Daily
07:42AM  Acorda Puts 4 Drugs On Back Burner After Patent Setback Investor's Business Daily
07:15AM  CORRECTING and REPLACING Acorda Provides Financial and Pipeline Update for First Quarter 2017 Business Wire
06:28AM  Acorda reports 1Q loss Associated Press
Apr-13-17 07:00AM  Acorda to Host Conference Call to Discuss First Quarter 2017 on April 27, 2017 Business Wire
Apr-10-17 05:00AM  Bass Battled U.S. Drug Patents and Prices But Lost to Cabal Bloomberg
Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops CVT-301 that has completed a Phase III clinical trial for the treatment of OFF periods in Parkinson's disease; CVT-427, which has completed a Phase I clinical trial to treat migraine; Tozadenant that is in Phase III clinical trial for reduction of OFF time in Parkinson's disease; SYN120, which is in Phase II clinical trial to treat Parkinson's disease-related dementia; and BTT1023 (timolumab) that is in Phase II clinical trial for primary sclerosing cholangitis. Further, it develops rHIgM22, which is in Phase I clinical trial for the treatment of MS; Cimaglermin alfa that has completed a Phase I clinical trial in heart failure patients; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury. The company has collaborations and license agreements with Biogen International GmbH; Alkermes plc; Rush-Presbyterian St. Luke's Medical Center; Alkermes, Inc.; SK Biopharmaceuticals Co., Ltd.; Astellas Pharma Europe Ltd.; Canadian Spinal Research Organization; Cambridge Enterprise Limited and King's College London; Mayo Foundation for Education and Research; Paion AG; Medarex, Inc.; and Brigham and Women's Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAWRENCE DAVIDChief, Bus. Ops & PAOOct 09Sale25.402506,3508,686Oct 11 03:57 PM
SCOPIA CAPITAL MANAGEMENT LP10% OwnerAug 29Buy19.23766,20114,730,4498,474,728Aug 31 04:50 PM
Greene Barry EDirectorAug 01Option Exercise18.2110,000182,10010,000Aug 03 04:06 PM
RAUSCHER STEVEN MDirectorAug 01Option Exercise18.2110,000182,10010,000Aug 03 04:08 PM
Greene Barry EDirectorAug 01Sale21.5710,000215,6970Aug 03 04:06 PM
RAUSCHER STEVEN MDirectorAug 01Sale21.5710,000215,7030Aug 03 04:08 PM
Randall LorinDirectorJul 31Option Exercise18.2110,000182,10010,000Aug 02 04:05 PM
Randall LorinDirectorJul 31Sale21.6610,000216,6150Aug 02 04:05 PM
COHEN RONPresident and CEOJun 16Buy16.9520,000338,998511,648Jun 20 03:52 PM
Hindman Andrew A.Chief Business Dev. OfficerMay 15Sale15.757,704121,31946,123May 17 03:57 PM
Blight AndrewChief Scientific OfficerFeb 09Option Exercise22.1367,5861,495,678144,144Feb 13 04:13 PM
Greene Barry EDirectorFeb 09Option Exercise22.1372316,000723Feb 13 04:14 PM
LAWRENCE DAVIDChief, Bus. Ops & PAOFeb 09Option Exercise22.1363,1831,398,24067,719Feb 13 04:15 PM
Wasman JanePresident, Intl and GCFeb 09Option Exercise22.1354,5361,206,882156,210Feb 13 04:16 PM
LAWRENCE DAVIDChief, Bus. Ops & PAOFeb 09Sale22.3263,1831,410,5424,536Feb 13 04:15 PM
Greene Barry EDirectorFeb 09Sale22.6572316,3760Feb 13 04:14 PM
Blight AndrewChief Scientific OfficerFeb 09Sale22.4167,5861,514,37976,558Feb 13 04:13 PM
Wasman JanePresident, Intl and GCFeb 09Sale22.3054,5361,216,218101,674Feb 13 04:16 PM
Greene Barry EDirectorJan 03Option Exercise15.913,01748,0003,017Jan 05 04:12 PM
Greene Barry EDirectorJan 03Sale19.263,01758,1130Jan 05 04:12 PM
COHEN RONPresident and CEODec 14Option Exercise15.4940,172622,264519,860Dec 16 08:08 AM
COHEN RONPresident and CEODec 14Sale20.7540,172833,655479,688Dec 16 08:08 AM
Blight AndrewChief Scientific OfficerDec 01Sale20.764,855100,77476,558Dec 05 05:03 PM
Wasman JanePresident, Intl and GCDec 01Sale20.743,34769,400101,674Dec 05 05:15 PM
Sabella Lauren MChief Commercial OfficerDec 01Sale20.742,42950,38111,949Dec 05 05:14 PM
LAWRENCE DAVIDChief, Bus. Ops & PAODec 01Sale20.744,41691,5944,536Dec 05 05:11 PM
Hindman Andrew A.Chief Business Dev. OfficerDec 01Sale20.724439,18049,227Dec 05 05:09 PM
COHEN RONPresident and CEODec 01Sale20.747,160148,482479,688Dec 05 05:08 PM
BLANK BURKHARDChief Medical OfficerDec 01Sale20.7410,000207,44240,000Dec 05 05:06 PM
Batycky Richard P.Chief Tech. Off. & Site HeadOct 21Sale20.302,06341,87745,916Oct 25 07:06 AM